Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-08

Clinical Trial Update: Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study

View source ↗

Summary

This completed case-control clinical trial evaluated Brucella antibody seroprevalence in high-risk patients with low back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elham Ahmed Hassan | Conditions: Brucellosis, Low Back Pain | Status: COMPLETED